A型肉毒毒素注射在改善面上部动力性皱纹的疗效及可行性分析

目的:探讨A型肉毒毒素改善面上部动力性皱纹的临床疗效,并分析其可行性。方法:选择2016年2月到2016年10月在我院接受面上部动力性皱纹改善治疗的患者35例作为研究对象,所有患者均给予注射A型肉毒毒素治疗。评价并比较患者在治疗后30 min、治疗后3 d、治疗后7 d的优良率。采用面部皱纹量表(FWS)评价患者面部皱纹严重程度指数,比较患者治疗前、治疗后4周及治疗后6月的FWS指数。观察并比较治疗后面上部紧绷感、乏力感、注射点局部瘀斑等不良反应发生情况。结果:患者治疗后30 min、3 d及7 d时的优良率逐渐升高,治疗后3 d、7 d的优良率明显高于治疗后30 min,治疗后7 d的优良率明显高于治疗后3 d,差异均具有统计学意义(P0.05)。患者治疗后4周和治疗后6月的FWS指数均明显小于治疗前,并且治疗后4周的FWS指数明显小于治疗后6月,差异均具有统计学意义(P0.05)。治疗后,仅有4例患者出现轻微不适,所有症状均于休息3-4 d后自行消失,不影响患者的正常工作和生活。结论:A型肉毒毒素改善面上部动力性皱纹的临床疗效显著,维持时间较长,不良反应较少且较轻,安全性较好,值得在临床上推广应用。

Clinical Efficacy of Botulinum Toxin type A Injection in the Treatment of Upper Facial Dynamic Wrinkles and Feasibility Analysis

ABSTRACT Objective: To study the clinical efficacy of botulinum toxin type A injection in the treatment of upper facial dynamic wrinkles. Methods: A total of 35 patients with upper facial dynamic wrinkles treated in our hospital from February 2016 to October 2016 were selected as research objects. All the patients were treated with botulinum toxin type A. The excellence rate of 30min after treatment,3 d after treatment and 7 d after treatment were evaluated and compared. The facial wrinkles severity index of the patients were evaluated by the facial wrinkles scale (FWS), and the differences of the FWS index before treatment, 4 weeks after treatment and 6 months after treatment were compared. The adverse reactions, like upper facial tension, fatigue and local injection of ecchymosis after treatment were observed and compared. Results: The excellence rate of the patients after treatment of 30 min, 3 d and 7 d were gradually increased. The excellence rate of the patients after treatment of 3 d and 7 d were significantly higher than that of after treatment of 30 min, and the excellence rate of the patients after treatment of 7 d were significantly higher than that of after treatment of 3 d (P<0.05). The FWS index of the patients after treatment of 4 weeks and 6 months were significantly lower than those of before treatment, and the FWS index of the patients after treatment of 4 weeks were significantly lower than that of 6 months after treatment(P<0.05). After treatment, only 4 patients had slight discomfort and all of these symptoms were disappeared after 3-4 days, there was no effect on their normal work and life. Conclusion: Botulinum toxin type A injection has a remarkable clinical curative effect in the treatment of patients with upper facial dynamic wrinkles, can maintain for a long time, and also has good safety, it is worthy clinical application.